Welcome to our dedicated page for Envista Holdings news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings stock.
Envista Holdings Corporation reports recurring developments as a global dental products company serving dental professionals through consumables, technologies, equipment and services. Its public updates center on quarterly results, core sales trends, adjusted earnings measures, cash flow, share repurchase activity and management presentations at healthcare conferences.
Company news also covers product and brand activity across DEXIS, Kerr, Nobel Biocare and Ormco, including dental implants, orthodontics, digital imaging, restorative and endodontic solutions. Recent product announcements include Kerr Dental's ZenSeal Pro with ZenSave Tips, reflecting Envista's focus on dental workflow, treatment technology and clinician-facing product commercialization.
Envista Holdings Corporation (NYSE: NVST) will announce third quarter financial results on October 29, 2020, followed by a conference call at 2:00 PM PT. The call will be accessible via the company's website, where both the earnings press release and an accompanying slide presentation will be available. Envista, which emerged as an independent company in 2019, serves the dental industry with a robust portfolio of brands and solutions. The company focuses on improving patient care through innovative dental products and technology.
Envista Holdings Corporation (NYSE: NVST) will participate in two upcoming healthcare conferences. The first is the Baird 2020 Global Healthcare Conference on September 9, 2020, where CEO Amir Aghdaei will present from 10:50 to 11:20 AM ET. The second event, the Morgan Stanley 18th Annual Global Healthcare Conference, is scheduled for September 16, 2020, with Aghdaei presenting from 4:15 to 4:45 PM ET. Investors can access these presentations on Envista's Investor Relations website.
Envista Holdings Corporation (NYSE: NVST) reported a net loss of $93.5 million, or $0.59 per share, for Q2 2020, marking a 49.2% decline in sales year-over-year to $362.0 million. Core sales dropped 46.2%, attributable to the COVID-19 pandemic impacts. Despite the losses, the company noted a sequential improvement in sales each month. Cost reduction measures exceeded $100 million, including workforce adjustments. Although no guidance for 2020 was provided due to uncertainties, management expressed optimism regarding recovery in the dental market and ongoing restructuring efforts.
Envista Holdings Corporation (NYSE: NVST) will announce its second-quarter 2020 financial results on July 30, 2020. The results will be discussed in a conference call starting at 2:00 PM PT, with a duration of approximately one hour. Interested parties can access the call by dialing 866-648-5306 (U.S.) or +1 602-563-8479 (international) with conference ID # 1571434. A replay will be available until August 13, 2020. Investors can view the earnings press release and related materials on the company's website.